SCHEMBL2913235

SCHEMBL2913235

CCCCCCCCCCCCCCCCCCCCCCC(C)(C)C[C@H](N)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 3/20 0.53
GRIK2 Q13002 2/20 0.53
SLC1A2 P43004 2/20 0.50
SLC1A1 P43005 2/20 0.50
SLC1A3 P43003 1/20 0.47
FFAR1 O14842 2/20 0.42
CPT2 P23786 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
NOD1 Q9Y239 2/20 0.42
DDAH1 O94760 1/20 0.41
GPR84 Q9NQS5 3/20 0.40
KIF11 P52732 1/20 0.39
MAPT P10636 1/20 0.39
LCK P06239 1/20 0.39
PPARD Q03181 1/20 0.39
ZDHHC20 Q5W0Z9 1/20 0.39
ZDHHC2 Q9UIJ5 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23836645 1.00 GRIK1 (0.53) GRIK1GRIK2SLC1A2SLC1A1SLC1A3
SCHEMBL18775013 1.00 GRIK1 (0.53) GRIK1GRIK2SLC1A2SLC1A1SLC1A3
SCHEMBL18775015 0.98 GRIK1 (0.51) GRIK1GRIK2SLC1A2SLC1A1SLC1A3
SCHEMBL18775024 0.93 SLC1A2 (0.50) GRIK1GRIK2SLC1A2SLC1A1SLC1A3
SCHEMBL18775019 0.93 SLC1A2 (0.50) GRIK1GRIK2SLC1A2SLC1A1SLC1A3
SCHEMBL18775012 0.93 SLC1A2 (0.50) GRIK1GRIK2SLC1A2SLC1A1SLC1A3
SCHEMBL25006715 0.86 GRIK1 (0.53) GRIK1GRIK2SLC1A2SLC1A1SLC1A3
SCHEMBL18762598 0.85 SLC1A2 (0.44) GRIK1GRIK2SLC1A2SLC1A1SLC1A3
SCHEMBL18775003 0.85 SLC1A2 (0.44) GRIK1GRIK2SLC1A2SLC1A1SLC1A3
SCHEMBL18775000 0.85 SLC1A2 (0.44) GRIK1GRIK2SLC1A2SLC1A1SLC1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110300115-A1 USE OF INDUCTOR AGENTS GSE24.2 FOR PRODUCING PHARMACEUTICAL COMPOSITIONS FOR TREATING ILLNESSES RELATING TO CELLULAR SENESCENCE CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) 2011-12-08 US disclosed
EP-2216043-A1 USE OF INDUCTOR AGENTS GSE24.2 FOR PRODUCING PHARMACEUTICAL COMPOSITIONS FOR TREATING ILLNESSES RELATING TO CELLULAR SENESCENCE Consejo Superior De Investigaciones Científicas (ES) 2010-08-11 EP disclosed